NCT00716976
Clinical Trial Information
Trial Number: NCT00716976 (ClinicalTrials.gov)
Disease Type:
- Bone Neoplasm - Osteosarcoma
- CNS Neoplasm (Primary Tumor) - Embryonal Tumors
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Gastrointestinal Neoplasm - Liver and Hepatobiliary Cancer
- Germ Cell Neoplasm - Miscellaneous
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children
Study ID:
ACCL0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00716976-D3 | NCT00716976-D3 One row for each of the 194 serious adverse events detailed on manuscript page 69. These events are reported through the National Cancer Institute, Cancer Therapy Evaluation Program, Adverse Event Reporting System (CTEP-AERS). |
| NCT00716976-D2 | NCT00716976-D2 These data provide the incidence of toxicities. There is one record per patient-cycle. analysiset2=1 for rows included in Table 3 construction. analysiset3=1 for rows included in Table 4 construction. |
| NCT00716976-D1 | NCT00716976-D1 There is one row for each patient enrolled. The first 14 variables are used to make Figure 1. Patients considered for analysis of study outcomes have the variable analysiset1=1. Variables 15-50 provide patient characteristics (Table 1), outcome (Figures 2 and 3) and hearing loss comparisons (Table 2). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®